All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Wegovy Results After 1 Week: What to Expect

Wegovy results after 1 week on the 0.25 mg dose. Covers realistic weight expectations, appetite changes, common side effects, and how to make the most...

By Dr. Michael Torres, MD|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Michael Torres, MD · Reviewed by Dr. David Kim, MD, FACE

Wegovy Results After 1 Week: What to Expect custom 2026 header image for GLP-1 Weight Loss
Custom header image for Wegovy Results After 1 Week: What to Expect, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Wegovy Results After 1 Week: What to Expect

Wegovy results after 1 week on the 0.25 mg dose. Covers realistic weight expectations, appetite changes, common side effects, and how to make the most...

Short answer

Wegovy results after 1 week on the 0.25 mg dose. Covers realistic weight expectations, appetite changes, common side effects, and how to make the most...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Wegovy results after 1 week on the 0.25 mg dose. Covers realistic weight expectations, appetite changes, common side effects, and how to make the most of your first week.

Wegovy results after 1 week are going to be underwhelming if you're expecting a dramatic transformation, and that's exactly how it should be. The 0.25 mg starting dose is one-tenth of the full maintenance dose. It exists to help your body adjust with minimal side effects. Most patients notice mild appetite changes and possibly light nausea, but the scale barely moves. Here is a detailed look at what happens and what to do about it.

Your First Week on Wegovy: Day by Day

DayWhat Most Patients Experience
Day 1 (Injection)Quick, easy injection. Slight sting that lasts a second. Most people carry on with their normal day. Some feel a subtle "awareness" in their stomach by evening.
Day 2About 1 in 3 patients notices mildly reduced hunger. Others feel completely normal. Occasional light nausea, usually brief.
Day 3If appetite changes are going to appear, they usually show up by now. Meals may feel slightly more satisfying. Food portions may naturally decrease without effort.
Day 4-5Nausea (if present) typically starts fading. Appetite effects may fluctuate. Some patients notice reduced cravings for sweets or fried foods.
Day 6-7Your body is adjusting. Most patients feel fairly normal. The effects at 0.25 mg are gentle and easy to live with. Time for your second injection on day 7 or 8.

Weight Loss Reality Check

Here is what the data tells us about weight loss during the first week of Wegovy.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Wegovy Results After 1 Week: What to Expect

Clinical Trial Data

In the STEP 1 trial[1], participants on semaglutide 2.4 mg (Wegovy) lost an average of 14.9% of their body weight over 68 weeks. But almost none of that loss happened during the first week at 0.25 mg. At the 4-week mark (still on 0.25 mg), the average weight change was approximately 0.5 to 1% of body weight. That puts the week 1 contribution at roughly 0.1 to 0.3% of body weight. For a complete cost breakdown, see our compare semaglutide prices.

What This Means in Pounds

Your Starting WeightExpected Week 1 LossPerspective
170 lbs0-1 lbLess than normal daily fluctuation
210 lbs0-1.5 lbsHard to distinguish from water weight changes
250 lbs0-2 lbsReal fat loss starts at higher doses
300 lbs0-2.5 lbsPatience now leads to major results later

Why This Is Actually Good News

Slow starts produce better long-term outcomes. Patients who experience rapid early weight loss often face worse side effects, higher dropout rates, and more muscle loss. The gradual escalation from 0.25 mg to 2.4 mg over 16 weeks is designed to produce sustainable, primarily fat-based weight loss. Wegovy weight loss timeline

Common Side Effects at 0.25 mg

The 0.25 mg dose is the gentlest in the Wegovy escalation. Side effects at this level are milder than at any subsequent dose.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
  • Nausea: Affects about 15% of patients. Typically mild, lasts 1-3 days, and improves before the second injection
  • Reduced appetite: The intended effect. If you feel slightly less hungry between meals, the medication is working
  • Constipation: Reported by 5-8% of patients. Increase water and fiber intake. A magnesium supplement or stool softener can help if needed
  • Headache: Occurs in some patients during the first few days. Usually mild and resolves with hydration and over-the-counter pain relief
  • Fatigue: A small percentage of patients feel slightly more tired than usual for the first 2-3 days

If you experience none of these, that's also completely normal. Many patients at 0.25 mg have no noticeable side effects at all. Wegovy side effects guide

How to Improve Your First Week

Injection Tips

  • Inject at room temperature (take the pen out of the fridge 30 minutes before)
  • Rotate injection sites: abdomen, thigh, or upper arm
  • Choose a consistent day each week that fits your schedule
  • Some patients prefer injecting in the evening so any nausea occurs during sleep

Eating Strategy

  • Protein at every meal: eggs, Greek yogurt, chicken, fish, legumes (25-30g per meal)
  • Eat when hungry but don't force large meals
  • Avoid foods that commonly trigger nausea: very greasy, very spicy, or very rich dishes
  • Small, frequent meals are easier to tolerate than 3 large ones during the adjustment period

Hydration

Drink at least 64 ounces of water daily. This helps with both constipation (common) and nausea (sometimes triggered by dehydration). Herbal tea and broth count toward your daily intake.

What Not to Do

  • Don't weigh yourself daily. Weekly weigh-ins are more meaningful
  • Don't dramatically cut calories. Your body needs adequate nutrition during the adjustment phase
  • Don't compare your week 1 to anyone else's. Responses are highly individual
  • Don't judge whether Wegovy "works" based on 7 days at a sub-therapeutic dose

Frequently Asked Questions

When will Wegovy start really working?

Most patients feel meaningful appetite suppression at the 0.5 mg dose (weeks 5-8) and see consistent weight loss from month 2-3 onward. The peak rate of weight loss typically occurs between months 4 and 8 at the 1.7 mg and 2.4 mg doses. Wegovy results timeline

Is it normal to gain weight during week 1?

Yes. Weight fluctuates daily due to water, food volume, and hormonal factors. A 1-2 pound increase on any given day doesn't mean the medication isn't working. Focus on the trend over weeks and months, not day-to-day numbers.

Can I skip the 0.25 mg dose and start higher?

We strongly advise against this. Skipping the introductory dose significantly increases the risk of nausea and vomiting, which can make you miserable and may cause you to abandon treatment. The 4-week introductory phase exists because clinical trials showed it improves tolerability and long-term adherence. Wegovy dosage schedule

Should I exercise more during week 1?

Maintain your current exercise routine but don't dramatically increase intensity. If you're new to exercise, start with daily walking. The best time to ramp up exercise is once you're tolerating the medication well and have established a protein-rich eating pattern.

Medical References

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]

The Road Ahead

Week 1 on Wegovy is just the opening chapter. You have 16 weeks of dose escalation ahead, followed by months of active weight loss at the 2.4 mg maintenance dose. The patients who achieve the best results are the ones who stay consistent through these early, slow weeks.

At FormBlends, we provide structured support from week 1 through your entire treatment plan.

Starting Wegovy? Get personalized guidance with a free assessment.

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Wegovy evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Wegovy Results After 1 Week: What to Expect, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Emerging pharmacotherapies for obesity: A systematic review

Broad context for new and established obesity-drug categories.

PubMed

ReviewObesity pharmacotherapy evidence2026

Glucagon-like receptor agonists and next-generation incretin-based medications

Current review for incretin-based obesity medications and cardiometabolic effects.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

Used as a class-level evidence anchor when no more specific citation group matches.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Wegovy Results After 1 Week: What to Expect research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Wegovy results after 1 week on the 0.25 mg dose. Covers realistic weight expectations, appetite changes, common side effects, and how to make the most of your first week. Read "Wegovy Results After 1 Week: What to Expect" as a GLP-1 treatment guide where medication choice, dosing, side effects, monitoring, and insurance rules can change the decision. The main job of this page is patient education and clinical context, especially where the topic touches semaglutide, side effects, dosing. Because this article has 6 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. Use it to ask sharper questions of a licensed clinician, not as a substitute for personal medical advice.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Wegovy Results After 1 Week

Wegovy Results After 1 Week now carries extra 2026 context around semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, wegovy, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation.

Instead of adding filler, this page keeps the named treatment terms, practical verification points, and next-step questions close to wegovy results after 1 week what to expect.

Readers should use the section to check current eligibility, pharmacy or provider policies, and safety questions with a licensed professional before acting.

Wegovy Results After 1 Week custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Wegovy Results After 1 Week, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Wegovy Results After 1 Week, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. Michael Torres, MD

Endocrinologist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.